BioNote (XKRX:377740) FCF Margin % : 42.32% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is BioNote FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioNote's Free Cash Flow for the three months ended in Mar. 2024 was ₩10,712 Mil. BioNote's Revenue for the three months ended in Mar. 2024 was ₩25,309 Mil. Therefore, BioNote's FCF Margin % for the quarter that ended in Mar. 2024 was 42.32%.

As of today, BioNote's current FCF Yield % is 4.25%.

The historical rank and industry rank for BioNote's FCF Margin % or its related term are showing as below:

XKRX:377740' s FCF Margin % Range Over the Past 10 Years
Min: -9.7 Med: 33.76 Max: 78.07
Current: 19.22

During the past 5 years, the highest FCF Margin % of BioNote was 78.07%. The lowest was -9.70%. And the median was 33.76%.

XKRX:377740's FCF Margin % is ranked better than
92.13% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.07 vs XKRX:377740: 19.22

BioNote FCF Margin % Historical Data

The historical data trend for BioNote's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote FCF Margin % Chart

BioNote Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

20.78

33.76

78.07

43.08

-9.70

BioNote Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial												-76.17	-57.93	90.90	10.87	42.32

Competitive Comparison of BioNote's FCF Margin %

For the Medical Devices subindustry, BioNote's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNote's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioNote's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioNote's FCF Margin % falls into.

BioNote FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioNote's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8735.625	/	90080.966
	=	-9.70 %

BioNote's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	10711.791	/	25308.838
	=	42.32 %

BioNote FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioNote's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNote (XKRX:377740) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR

Website

https://www.bionote.co.kr

BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote (XKRX:377740) Headlines

No Headlines